T

Teyi Pharmaceutical Group Co Ltd
SZSE:002728

Watchlist Manager
Teyi Pharmaceutical Group Co Ltd
SZSE:002728
Watchlist
Price: 8.85 CNY -4.53%
Market Cap: 4.5B CNY
Have any thoughts about
Teyi Pharmaceutical Group Co Ltd?
Write Note

Teyi Pharmaceutical Group Co Ltd
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Teyi Pharmaceutical Group Co Ltd
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
T
Teyi Pharmaceutical Group Co Ltd
SZSE:002728
Retained Earnings
ÂĄ484.5m
CAGR 3-Years
-1%
CAGR 5-Years
-4%
CAGR 10-Years
6%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Retained Earnings
ÂĄ11.7B
CAGR 3-Years
36%
CAGR 5-Years
61%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Retained Earnings
ÂĄ11.9B
CAGR 3-Years
17%
CAGR 5-Years
22%
CAGR 10-Years
25%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Retained Earnings
ÂĄ34.3B
CAGR 3-Years
10%
CAGR 5-Years
14%
CAGR 10-Years
20%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Retained Earnings
ÂĄ20.1B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
9%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Retained Earnings
-ÂĄ1.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Teyi Pharmaceutical Group Co Ltd
Glance View

Market Cap
4.5B CNY
Industry
Pharmaceuticals

Teyi Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and pharmaceutical health industry. The company is headquartered in Jiangmen, Guangdong and currently employs 1,200 full-time employees. The company went IPO on 2014-07-31. The firm primarily provides Chinese traditional patent medicines, including cough arresting and phlegm removing medicine series, kidney reinforcing medicine series and anti-infection medicine series, among others. The firm's products mainly include tablets, granules, medicinal tea, syrup, decocted extracts, capsules, powder, ointment, cream, as well as oral solutions, among others.

Intrinsic Value
11.64 CNY
Undervaluation 24%
Intrinsic Value
Price
T

See Also

What is Teyi Pharmaceutical Group Co Ltd's Retained Earnings?
Retained Earnings
484.5m CNY

Based on the financial report for Sep 30, 2024, Teyi Pharmaceutical Group Co Ltd's Retained Earnings amounts to 484.5m CNY.

What is Teyi Pharmaceutical Group Co Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
6%

Over the last year, the Retained Earnings growth was -19%. The average annual Retained Earnings growth rates for Teyi Pharmaceutical Group Co Ltd have been -1% over the past three years , -4% over the past five years , and 6% over the past ten years .

Back to Top